| [1] |
Messiou C, Moskovic E, Vanel D, et al. Primary retroperitoneal soft tissue sarcoma: imaging appearances, pitfalls and diagnostic algorithm[J]. Eur J Surg Oncol, 2017, 43(7):1191-1198.
doi: S0748-7983(16)31010-1
pmid: 28057392
|
| [2] |
Makise N, Yoshida A, Komiyama M, et al. Dedifferentia-ted liposarcoma with epithelioid/epithelial features[J]. Am J Surg Pathol, 2017, 41(11):1523-1531.
doi: 10.1097/PAS.0000000000000910
URL
|
| [3] |
Agaimy A, Michal M, Hadravsky L, et al. Dedifferentia-ted liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant[J]. Hum Pathol, 2018, 77:20-27.
doi: S0046-8177(17)30496-3
pmid: 29307627
|
| [4] |
Saada-Bouzid E, Burel-Vandenbos F, Ranchère-Vince D, et al. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas[J]. Mod Pathol, 2015, 28(11):1404-1414.
doi: 10.1038/modpathol.2015.96
URL
|
| [5] |
Schaefer IM, Lundberg MZ, Demicco EG, et al. Relationships between highly recurrent tumor suppressor alte-rations in 489 leiomyosarcomas[J]. Cancer, 2021, 127(15):2666-2673.
doi: 10.1002/cncr.33542
URL
|
| [6] |
Pérot G, Derré J, Coindre JM, et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas[J]. Cancer Res, 2009, 69(6):2269-2278.
doi: 10.1158/0008-5472.CAN-08-1443
pmid: 19276386
|
| [7] |
Colombo C, Miceli R, Lazar AJ, et al. CTNNB1 45F mutation is a molecular prognosticator of increased posto-perative primary desmoid tumor recurrence: an independent, multicenter validation study[J]. Cancer, 2013, 119(20):3696-3702.
doi: 10.1002/cncr.28271
pmid: 23913621
|
| [8] |
Demicco EG, Wagner MJ, Maki RG, et al. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model[J]. Mod Pathol, 2017, 30(10):1433-1442.
doi: 10.1038/modpathol.2017.54
URL
|
| [9] |
Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis[J]. Int J Urol, 2020, 27(5):387-394.
doi: 10.1111/iju.14218
pmid: 32166828
|
| [10] |
徐静, 张勇, 童汉兴, 等. 静脉内平滑肌瘤病的临床特征与外科治疗策略[J]. 中国临床医学, 2019, 26(3):369-373.
|
| [11] |
Fishbein L, Leshchiner I, Walter V, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma[J]. Cancer Cell, 2017, 31(2):181-193.
doi: S1535-6108(17)30001-6
pmid: 28162975
|
| [12] |
Muth A, Crona J, Gimm O, et al. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma[J]. J Intern Med, 2019, 285(2):187-204.
doi: 10.1111/joim.12869
pmid: 30536464
|
| [13] |
Burgues O, Navarro S, Noguera R, et al. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma(Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry[J]. Virchows Arch, 2006, 449(4):410-420.
doi: 10.1007/s00428-006-0253-y
URL
|
| [14] |
Hoshino Y, Yamada I, Shimano SI. Malignant lymphoma mimicking retroperitoneal fibrosis[J]. Intern Med, 2021, 60(20):3345-3346.
doi: 10.2169/internalmedicine.7142-21
URL
|
)
